These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 18223688)

  • 1. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
    Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D
    Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
    Fukutomi S; Seki N; Koda K; Miyazaki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.
    Kim MS; Lebron C; Nagpal JK; Chae YK; Chang X; Huang Y; Chuang T; Yamashita K; Trink B; Ratovitski EA; Califano JA; Sidransky D
    Biochem Biophys Res Commun; 2008 May; 370(1):38-43. PubMed ID: 18346456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
    Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of LRRC3B in colorectal cancer.
    Tian XQ; Zhang Y; Sun D; Zhao S; Xiong H; Fang J
    Scand J Gastroenterol; 2009; 44(1):79-84. PubMed ID: 18815942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
    Brait M; Ling S; Nagpal JK; Chang X; Park HL; Lee J; Okamura J; Yamashita K; Sidransky D; Kim MS
    PLoS One; 2012; 7(9):e44951. PubMed ID: 23028699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide screening for methylation-silenced genes in colorectal cancer.
    Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
    Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
    Akino K; Toyota M; Suzuki H; Imai T; Maruyama R; Kusano M; Nishikawa N; Watanabe Y; Sasaki Y; Abe T; Yamamoto E; Tarasawa I; Sonoda T; Mori M; Imai K; Shinomura Y; Tokino T
    Cancer Sci; 2007 Jan; 98(1):88-95. PubMed ID: 17083569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth.
    Kim MS; Chang X; Nagpal JK; Yamashita K; Baek JH; Dasgupta S; Wu G; Osada M; Woo JH; Westra WH; Trink B; Ratovitski EA; Moon C; Sidransky D
    Oncogene; 2008 Mar; 27(14):2045-54. PubMed ID: 17922030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
    Jung YY; Sung JY; Kim JY; Kim HS
    Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.
    Jee CD; Kim MA; Jung EJ; Kim J; Kim WH
    Eur J Cancer; 2009 May; 45(7):1282-1293. PubMed ID: 19195878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.
    Choi JS; Kim KH; Jeon YK; Kim SH; Jang SG; Ku JL; Park JG
    Int J Cancer; 2009 Mar; 124(6):1258-62. PubMed ID: 19089928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.